TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33871631

Group type: EXPERIMENTAL
Intervention: Intervention decision aid (evidence-based information on overdetection, breast cancer mortality reduction, and false-positives)
Number of subjects: 879

Group type: COMPARATOR
Intervention: Control decision aid (identical but without overdetection information)
Number of subjects: 879

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 879

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 879
Study: 34626144

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Blonanserin
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 251
Study: 33413494

Group type: EXPERIMENTAL
Intervention: EHR tools designed using behavioral principles (salience, choice architecture, defaulting)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Up to 5 most promising stage 1 interventions
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care (for stage 1 providers in unselected arms)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Quantities of medication prescribed and utilized
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Clinically significant adverse outcomes
Number of subjects: 81
Study: 34887183

Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB) using 0.5 mg/kg of 0.125% bupivacaine (Marcaine)
Number of subjects: 60
Study: 34157865

Group type: EXPERIMENTAL
Intervention: TICI 3
Number of subjects: 141

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 141
Study: 34196240

Group type: EXPERIMENTAL
Intervention: Face mask trials
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control trials (no mask)
Number of subjects: 12
Study: 33295955

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 240
Study: 35509876

Group type: EXPERIMENTAL
Intervention: Acupressure (3 days a week for 8 weeks)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Aerobic exercises (3 times a week for 8 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (routine care in the oncology clinic)
Number of subjects: 99
Study: 34835954

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum PS128
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36121246

Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN) plus a phosphodiesterase‐5 inhibitor
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sham procedure plus a phosphodiesterase‐5 inhibitor
Number of subjects: 128
Study: 33743111

Group type: EXPERIMENTAL
Intervention: Combination of four serum miRNAs (miR-4257, miR-6785-5p, miR-187-5p, and miR-5739)
Number of subjects: 1417

Group type: COMPARATOR
Intervention: Non-cancer controls
Number of subjects: 1417
Study: 35010502

Group type: EXPERIMENTAL
Intervention: Glycyrrhiza uralensis extract gargle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline gargle
Number of subjects: 60
Study: 34121477

Group type: EXPERIMENTAL
Intervention: Single medial incision
Number of subjects: 8

Group type: COMPARATOR
Intervention: 2‐incision technique
Number of subjects: 8
Study: 33276345

Group type: EXPERIMENTAL
Intervention: Sedentary behavior fragmentation (SBF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Light intensity physical activity (LIPA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study: 36314126

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 5741

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5741
Study: 32805278

Group type: EXPERIMENTAL
Intervention: Health-related image included on dietary supplement packaging
Number of subjects: 1016
Study: 35311937

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g in 100-mL intravenous bolus loading dose, followed by 1 g in 250-mL infusion within 8 hours of ICH onset)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo (0.9% saline within 8 hours of ICH onset)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 32799365

Group type: EXPERIMENTAL
Intervention: Synthetic polyethylene glycol (PEG) collagen membrane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Porcine-derived collagen membrane (CM)
Number of subjects: 30
Study: 36029489

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (0.25-0.5 mg/day) for eight weeks
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 104
Study: 33249906

Group type: EXPERIMENTAL
Intervention: Vitamin E-infused highly crosslinked polyethylene (VEPE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Moderately crosslinked polyethylene (ModXLPE)
Number of subjects: 68
Study: 34724213

Group type: EXPERIMENTAL
Intervention: 0.5% PVP-I nasal spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.0% PVP-I nasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups (including placebo)
Number of subjects: 0
Study: 34654501

Group type: EXPERIMENTAL
Intervention: CPP‐ACP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: NHA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: NovaMin®
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30

Group type: COMPARATOR
Intervention: Demineralization
Number of subjects: 30
Study: 35228081

Group type: EXPERIMENTAL
Intervention: Nalmefene
Number of subjects: 0
Study: 34373575

Group type: EXPERIMENTAL
Intervention: Cd2+ exposure for 3 hours (Gi 3h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cd2+ exposure for 3 days (Gi 3d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (0h)
Number of subjects: 0
Study: 32646501

Group type: EXPERIMENTAL
Intervention: unripe Rubus coreanus (uRC) 600 mg daily for 12 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 34170489

Group type: EXPERIMENTAL
Intervention: Treatment for anorexia nervosa
Number of subjects: 228
Study: 33567462

Group type: EXPERIMENTAL
Intervention: Pledgeted reinforced sutures
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 55
Study: 33837377

Group type: EXPERIMENTAL
Intervention: Drugs targeting IFNAR2
Number of subjects: 7554

Group type: EXPERIMENTAL
Intervention: Drugs targeting ACE2
Number of subjects: 7554
Study: 32459423

Group type: EXPERIMENTAL
Intervention: Elagolix 300 mg twice daily with hormonal add-back therapy (estradiol 1 mg and norethindrone acetate 0.5 mg once daily)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Elagolix plus add-back therapy
Number of subjects: 433
Study: 35246396

Group type: EXPERIMENTAL
Intervention: Intranasal low-level laser therapy (LLLT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture treatment (AT)
Number of subjects: 80
Study: 33152029

Group type: EXPERIMENTAL
Intervention: Fixed-gas concentration (FG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bispectral index-guided (BG)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 34874182

Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy
Number of subjects: 5761

Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 5761
Study: 32635503

Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH), 4 g daily for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo, 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36347150

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90
Study: 34037151

Group type: EXPERIMENTAL
Intervention: Traditional bed bath
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dry bed bath
Number of subjects: 50
Study: 32102615

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 13
Study: 34243225

Group type: EXPERIMENTAL
Intervention: Yoga intervention (1-hour session, 5 days a week for 1 month)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 82
Study: 32554744

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Cervical cerclage plus vaginal progesterone
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Cervical pessary plus vaginal progesterone
Number of subjects: 340
Study: 36189925

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid 0.2%/ Arnica extract 0.1% (Study Group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hyaluronic Acid 0.2% (Control Group)
Number of subjects: 52
Study: 33438505

Group type: EXPERIMENTAL
Intervention: Experienced surgeon
Number of subjects: 12

Group type: COMPARATOR
Intervention: Novice surgeon
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both surgeons
Number of subjects: 12
Study: 34191011

Group type: EXPERIMENTAL
Intervention: Rivaroxaban plus aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 34110842

Group type: EXPERIMENTAL
Intervention: Personalized Feedback Program (PFP) providing feedback on genetically influenced risk factors for substance use and personalized recommendations/resources.
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Online self-guided PFP developed in collaboration with professionals from student affairs and feedback from students.
Number of subjects: 12000
Study: 33108633

Group type: EXPERIMENTAL
Intervention: Oral siponimod 2 mg (initial dose titration over 6 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33769013

Group type: EXPERIMENTAL
Intervention: VirtualBasket technology
Number of subjects: 160

Group type: COMPARATOR
Intervention: Regular mode (Control)
Number of subjects: 160
Study: 35946019

Group type: COMPARATOR
Intervention: ACTH alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ACTH with Levetiracetam (LEV)
Number of subjects: 100
Study: 32557338

Group type: EXPERIMENTAL
Intervention: Stronger postoperative analgesia (75/650 mg tramadol with paracetamol every 8 hours)
Number of subjects: 117
Study: 34031117

Group type: EXPERIMENTAL
Intervention: Twice-weekly haemodialysis with adjuvant pharmacological therapy for 6 weeks followed by thrice-weekly haemodialysis (incremental HD group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Thrice-weekly haemodialysis (standard HD group)
Number of subjects: 50
Study: 32281125

Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 22650
Study: 33902372

Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg IV infusion
Number of subjects: 96

Group type: COMPARATOR
Intervention: Pethidine 50 mg IV infusion
Number of subjects: 96
Study: 33407589

Group type: EXPERIMENTAL
Intervention: Insufficient physical activity
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Prolonged screen time
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Insufficient sleeping time
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Consumption of sugar‐sweetened beverage
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Fast food intake
Number of subjects: 4388

Group type: EXPERIMENTAL
Intervention: Each additional lifestyle-related risk factor
Number of subjects: 4388
Study: 32718934

Group type: EXPERIMENTAL
Intervention: DSNS breakfast/afternoon snack (Bkfst/AS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: DSNS breakfast/prebed snack (Bkfst/PBS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: SSD group (control)
Number of subjects: 81
Study: 35405771

Group type: EXPERIMENTAL
Intervention: Gray titanium abutments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pink anodized titanium abutments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Zirconia abutments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pink anodized and zirconia hybrid abutments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Hybrid zirconia abutments
Number of subjects: 25
Study: 33407839

Group type: EXPERIMENTAL
Intervention: QPLEX™ Alz plus assay kit
Number of subjects: 300
Study: 33570656

Group type: EXPERIMENTAL
Intervention: WeChat-assisted dietary and exercise intervention
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (general advice session about pregnancy nutrition and weight management)
Number of subjects: 215
Study: 36383222

Group type: EXPERIMENTAL
Intervention: TAC-DMN
Number of subjects: 20

Group type: COMPARATOR
Intervention: Drug-free DMN
Number of subjects: 20
Study: 34459570

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 554

Group type: COMPARATOR
Intervention: Delayed or selective angiography
Number of subjects: 554
Study: 32960175

Group type: EXPERIMENTAL
Intervention: SUPR (web-based self-management support program)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 343
Study: 34226203

Group type: EXPERIMENTAL
Intervention: 6-week behaviour change intervention (weekly sessions with a physiotherapist)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham intervention (weekly phone calls to monitor health status)
Number of subjects: 70
Study: 35438802

Group type: COMPARATOR
Intervention: AZA (Azacitidine)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: AZA + Lenalidomide (LEN)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: AZA + Valproic Acid (VPA)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: AZA + Idarubicin (IDA)
Number of subjects: 322
Study: 32054421

Group type: EXPERIMENTAL
Intervention: Fish-borne trematode infections in wild fishes
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ticto barb (Puntius ticto)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Banded gourami (Colisa fasciata)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Freshwater garfish (Xenentodon cancila)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Flying barb (Esomus danricus)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Reba carp (Cirrhinus reba)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Body vs Head infection rates
Number of subjects: 65
Study: 36047474

Group type: EXPERIMENTAL
Intervention: Ponesimod 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teriflunomide 14 mg
Number of subjects: 0
Study: 33284089

Group type: EXPERIMENTAL
Intervention: Protein‐polyphenol beverage (PPB)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18
Study: 35392835

Group type: EXPERIMENTAL
Intervention: US-guided transoral core needle biopsy
Number of subjects: 112

Group type: COMPARATOR
Intervention: US-guided transcutaneous core needle biopsy
Number of subjects: 112
Study: 34117042

Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy programme (ESP)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release (ACR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Hydrodilatation
Number of subjects: 44
Study: 32615727

Group type: EXPERIMENTAL
Intervention: Lactobacillus sakei (CJLS03) 5×10^9 colony-forming units, administered for 12 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (equivalent vehicle), administered for 12 weeks
Number of subjects: 114
Study: 34024615

Group type: EXPERIMENTAL
Intervention: External stent
Number of subjects: 184

Group type: COMPARATOR
Intervention: Nonstented saphenous vein graft
Number of subjects: 184
Study: 32877317

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 35880559

Group type: EXPERIMENTAL
Intervention: Polymer-free stents (PFS)
Number of subjects: 1664

Group type: COMPARATOR
Intervention: Polymer-coated stents (PCS)
Number of subjects: 1664
Study: 32506861

Group type: EXPERIMENTAL
Intervention: Huatan Jieyu granules
Number of subjects: 107

Group type: COMPARATOR
Intervention: Basic treatment with prednisone
Number of subjects: 107
Study: 35249798

Group type: EXPERIMENTAL
Intervention: Multimodal intensive educative program (5 hours a week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual practice of an educative program (1 hour a week)
Number of subjects: 60
Study: 33493406

Group type: EXPERIMENTAL
Intervention: Wrap crural fixation
Number of subjects: 46

Group type: COMPARATOR
Intervention: No wrap fixation (Control Group B)
Number of subjects: 46
Study: 33170877

Group type: EXPERIMENTAL
Intervention: Web-based decision aid for colorectal cancer screening
Number of subjects: 1723

Group type: COMPARATOR
Intervention: Control group (second reminder only)
Number of subjects: 1723
Study: 35532913

Group type: EXPERIMENTAL
Intervention: ACI-24 vaccine (300 μg or 1000 μg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34665203

Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (31 °C)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Mild hypothermia (34 °C)
Number of subjects: 389
Study: 33119643

Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Well-Restedness (WR)
Number of subjects: 0
Study: 35485939

Group type: EXPERIMENTAL
Intervention: Weekly digital interventions assessing treatment adherence
Number of subjects: 29

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 29
Study: 33819218

Group type: EXPERIMENTAL
Intervention: Purse-string closure (Group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Linear closure (Group B)
Number of subjects: 72
Study: 35610696

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Linagliptin 5 mg daily
Number of subjects: 60
Study: 35710448

Group type: EXPERIMENTAL
Intervention: Online vestibular rehabilitation tool (YrselTräning)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard care (written instructions leaflet)
Number of subjects: 320
Study: 32501212

Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA) therapy
Number of subjects: 18
Study: 33728462

Group type: COMPARATOR
Intervention: Diethylcarbamazine and Albendazole (DA)
Number of subjects: 3816

Group type: EXPERIMENTAL
Intervention: Ivermectin, Diethylcarbamazine, and Albendazole (IDA)
Number of subjects: 3816

Group type: COMPARATOR
Intervention: Control (DA) and Intervention (IDA)
Number of subjects: 3816
Study: 32022459

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 108
Study: 36399252

Group type: EXPERIMENTAL
Intervention: Rise intervention (one-on-one counseling sessions using Motivational Interviewing)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Rise intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 34222771

Group type: EXPERIMENTAL
Intervention: Moderate-volume surgeons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-volume surgeons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very-low-volume surgeons
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-volume centres
Number of subjects: 0
Study: 35640658

Group type: EXPERIMENTAL
Intervention: Bayesian AUC24-48
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bayesian AUC48-72
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bayesian AUC72-96
Number of subjects: 65

Group type: COMPARATOR
Intervention: First-order pharmacokinetic equation methods
Number of subjects: 65
Study: 34337527

Group type: EXPERIMENTAL
Intervention: Pigtail suture stent (PSS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional double J stent (DJ)
Number of subjects: 78
Study: 33960006

Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation (rTMS) with cognitive processing therapy (CPT+A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation (rTMS) with cognitive processing therapy (CPT+A)
Number of subjects: 60
Study: 33408364

Group type: EXPERIMENTAL
Intervention: Lab4P probiotic (50 billion cfu/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 36135352

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-based paste applied on 2 MIH teeth in one random quadrant (test group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (2 contralateral MIH teeth did not undergo paste application)
Number of subjects: 25
Study: 33451345

Group type: EXPERIMENTAL
Intervention: xentuzumab/everolimus/exemestane
Number of subjects: 140

Group type: COMPARATOR
Intervention: everolimus/exemestane
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: xentuzumab/everolimus/exemestane (subgroup without visceral metastases)
Number of subjects: 140

Group type: COMPARATOR
Intervention: everolimus/exemestane (subgroup without visceral metastases)
Number of subjects: 140
Study: 32871327

Group type: EXPERIMENTAL
Intervention: OCT-guided PCI strategy
Number of subjects: 2000

Group type: COMPARATOR
Intervention: IVUS-guided PCI strategy
Number of subjects: 2000
Study: 35962199

Group type: EXPERIMENTAL
Intervention: Invasive strategy with systematic myocardial revascularization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 0
Study: 34704480

Group type: EXPERIMENTAL
Intervention: Infliximab (anti-tumor necrosis factor antibody)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative application of mesenchymal donor stem cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotics and/or seton drainage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical strategies (fistulotomy, disconnection of the fistula, filling of the fistula tract, fistula ablation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anorectal physiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapy directed against intestinal inflammation
Number of subjects: 0